• 제목/요약/키워드: Nuclear medicine study

검색결과 2,892건 처리시간 0.028초

휴식 T1-201/부하 Tc-99m MIBI 심근 SPECT의 관상동맥질환 진단 정확성 (Diagnostic Accuracy of Rest T1-201/Stress Tc-99m-MIBI Myocardial SPECT in the Diagnosis of Coronary Artery Disease)

  • 여정석;이동수;강건욱;손대원;오병희;이명묵;정준기;박영배;이명철;서정돈;이영우;고창순
    • 대한핵의학회지
    • /
    • 제30권1호
    • /
    • pp.112-117
    • /
    • 1996
  • 휴식 T1-20l/부하 Tc-99m MIBI 지연 T1-201 심근 SPECT는 관상동맥질환을 진단하는데 87%의 진단 정확성을 보여 기존의 부하/휴식 Tc-99m MIBI SPECT와 비교하여 비슷하거나 더 좋은 성능을 보였다. 이 연구로써 휴식 T1-201/부하 Tc-99m MIBI 심근 SPECT 방법의 관동맥질환 진단성능은 다른 방법들과 비슷함을 확인하였다. 또한 이 방법은 진정한 의미의 휴식기 영상을 얻을 수 있고 휴식기와 부하기 영상사이에 남아있던 방사능으로 인한 오차에서 벗어날 수 있으며 T1-201의 재분포영상과 24시간 지연영상으로부터 지속관류감소 부위의 생존여부에 대한 정보를 얻을 수 있고 휴식기 촬영후 바로 부하기 촬영을 하므로 전체 검사시간이 줄어 환자에게 편리하고 효율이 높아, 지연 T1-201 SPECT의 심근 생존능 판별성능이 확인되면 관동맥질환의 진단과 생존심근을 찾는 검사로 유용할 가능성이 있음을 알았다.

  • PDF

유방암 수술환자가 Tamoxifen복용기간 중 발생하는 FSH와 E2의 수치 변화 (Changes in Figures of FSH and E2 while Breast Cancer Patients Treated with Surgery takes Tamoxifen)

  • 권원현;문기춘;김혜숙;이인원;신숙희
    • 핵의학기술
    • /
    • 제14권2호
    • /
    • pp.186-189
    • /
    • 2010
  • Purpose: As many patients often showed the value of menopause although they were women of childbearing age, this study looked into their previous history. According to the findings, they were patients with a mastectomy due to breast cancer and were taking breast cancer treatment Tamoxifen (the women hormone inhibitor) after chemotherapy. This study is conducted to examine changes in FSH and E2 concentration of patients breast cancer patients of childbearing age according to Tamoxifen used to prevent recurrence of breast cancer and proliferation of mammary parenchyma. Materials and Methods: This study aims to investigate similarity in patients treated with surgery who were in their childbearing age and in values of FSH and E2 by dividing test results of FSH and E2 requested at the department of nuclear medicine among patients who visited this hospital from Jan. 2009 to Mar. 2010 into women of childbearing age (n=50), menopausal women (n=50), and patients with breast cancer surgery who take Tamoxifen (n=50) and then comparing the test results. Results: The FSH and E2 test results of 50 patients were compared and analyzed as average${\pm}$standard deviation, and the results showed that the figure of women of childbearingage (n=50) was FSH : $7.14{\pm}6.19$, E2 : $138.76{\pm}85.40$, that of menopausal women (n=50) was FSH : $52.12{\pm}24.43$, E2 : $15.06{\pm}4.43$, and that of patients with breast cancer surgery who were in their childbearing age (n=50) was FSH : $44.21{\pm}21.07$, E2 : $13.53{\pm}4.26$. When these different results of FSH and E2 were compared, the value of patients with breast cancer surgery who were in their childbearing age with Tamoxifen was somewhat similar to that of menopausal women. Conclusion: The test results of FSH and E2 have reportedly found the test values of patients with breast cancer surgery could be similar to that of menopausal women eventhough they were in their childbearing age due to the women hormone inhibitor Tamoxifen. Therefore, if a tester conducts this experiment after understanding the clinical meaning, the reliability of the tester reporting test results would be increased.

  • PDF

채혈 시간에 따른 부신피질 자극 호르몬 검사의 참고치 설정에 관한 고찰 (Consideration for Setting Reference Range for Adrenocorticotropic Hormone Test according to Blood Collection Time)

  • 박지혜;최진주;임수연;유선희;이선호
    • 핵의학기술
    • /
    • 제27권1호
    • /
    • pp.42-46
    • /
    • 2023
  • Purpose The reference range described in Adrenocorticotropic Hormone reagent used in our laboratory is 10-60 pg/mL at 8 a.m. to 10 a.m., and 6-30 pg/mL at 8 p.m. to 10 p.m. However, in the case of outpatients, blood is mainly collected between 10 a.m. and 6 p.m., accounting for 57.8% of the total. Therefore, This study is intended to help make a more accurate diagnosis by reevaluating the reference range provided by the manufacturer of the Adrenocorticotropic Hormone reagent and setting split-timed reference range. Materials and Methods The patients collected blood before 10 a.m. were group A (68 people), and the patients collected blood after 10 a.m. were set to group B (80 people). A T-test was performed between groups to test their significance. And it was confirmed whether it was necessary to set the gender classification as a subgroup. The method of setting the reference range was calculated by the Bayesian's method and the Hoffmann's method. Results The reference range of Group A was 8.6 to 60.6 pg/mL by the Bayesian's method, and the Hoffmann's method was 3.6 to 61.3 pg/mL. The reference range of Group B was 6.9 to 50.5 pg/mL when applying the Bayesian's method, and the Hoffmann method's was 2.3 to 48.9 pg/mL. Conclusion This study was concluded that it was necessary to set the split-timed reference range. Through this study, the later the blood collection time, the lower the level of Adrenocorticotropic Hormone, indicating that blood collection time is important for patients with clinical significance. If a large number of subjects are selected and supplemented in the future, it is believed that systematic and accurate reference range can be set.

  • PDF

${\alpha}_4{\beta}_2$ 니코틴성 아세틸콜린 수용체 영상 방사성리간드 $2-[^{18}F]fluoro-A85380$의 합성 및 평가 (Synthesis and Evaluation of $2-[^{18}F]Fluoro-A85380$, a Radioligand for ${\alpha}_4{\beta}_2$ Nicotinic Acetylcholine Receptor Imaging)

  • 류은경;최연성;김상은;황세환;백진영;최용;이경환;김병태
    • 대한핵의학회지
    • /
    • 제36권4호
    • /
    • pp.261-270
    • /
    • 2002
  • 목적: nAChRs의 ${\alpha}_4{\beta}_2$ 아형에 높은 친화력과 선택성을 갖는 리간드인 $2-[^{18}F]fluoro-A85380([^{18}F]1)$의 효율적인 합성과정을 연구하여 방사화학적 수율, 비방사능, 합성시간, 마우스에서 생물학적 평가의 측면에서 문헌에 보고된 결과들과 비교 평가하였다. 대상 밀 방법: 전구물질의 I을 $^{18}F$으로 치환한 다음 중간물질을 분리하지 않고 trifluoroacetic acid를 가하여 보호기를 제거하였다. 반응혼합액을 HPLC로 정제하여 얻은 방사성리간드($[^{18}F]1$)를 마우스의 꼬리 정맥에 주사한 후에 정해진 시간별로 6개의 뇌조직 (소뇌, 해마, 선조체, 피질, 시상, 상구)을 분리하여 무게를 측정하고 감마계수기를 이용하여 방사능을 측정하였다. 또한 스코폴라민, 메카밀아민, 사이티신, (-)니코틴, 비방사성 표준물질(1)을 마우스에 피하주사로 투여하고 방사성리간드 주사 후 90분에 6개의 뇌조직을 분리하여 무게 및 방사능을 측정하여 %ID/g으로 나타내었다. 이 결과를 대조군과 비교하였다. 결과: $^{18}F$ 표지 후 중간물질을 분리하지 않고 한 번의 HPLC 정제를 통하여 $[^{18}F]1$을 15-20%의 방사화학적 수율로 합성하였으며 비방사능은 $38-55GBq/{\mu}mol$이었다. 이 방사성리간드의 마우스 뇌에서의 분포결과, 주사 후 30분에 nAChRs가 풍부하게 분포되어 있는 시상과 상구에서 가장 많은 섭취를 보였고 이 수용체가 부족한 소뇌에는 거의 섭취되지 않았다. 여러 리간드를 사용하여 $[^{18}F]1$ 섭취의 억제효과를 본 실험에서는 nAChRs 작용제인 사이티신 및 (-)니코틴의 전처리가 시상 및 상구에서 $[^{18}F]1$의 섭취를 70-90% 감소시켰으며, 소뇌에서는 억제효과가 관측되지 않았다. 결론: 이 연구에서 사용된 방법으로 얻어진 $[^{18}F]1$의 방사화학적 수율, 비방사능, 뇌에서의 분포 그리고 여러 리간드에 의한 억제효과는 문헌에 보고된 결과와 유사하였다. 따라서 중간물질을 분리하지 않고 한번의 HPLC를 사용하는 방법이 $[^{18}F]1$의 상용생산에 유용하게 사용될 수 있을 것으로 기대한다.

핵의학과 일반 의료폐기물에서의 방사능 오염에 관한 고찰 (A Study on Medical Waste Contaminated by Radioactivity in Nuclear Medicine Department)

  • 유재숙;장정찬;이동훈;차민경;남기표
    • 핵의학기술
    • /
    • 제15권1호
    • /
    • pp.70-74
    • /
    • 2011
  • 서울 아산병원 핵의학과에서는 방사성폐기함을 다수 비치하여 방사성폐기물을 수집하고 있으나 이러한 방사성폐기물이 일반 의료폐기함에서 발견되는 경우가 있다. 이에 본 연구에서는 의료폐기물에서 측정되는 방사성폐기물의 발생 원인을 파악하여 방사선관리구역으로부터 배출되는 물품 표면의 방사성물질의 오염도가 허용표면오염도의 10분의 1을 초과하지 않거나 교육과학기술부에서 고시하는 액체폐기물이 방사성 자체 폐기한도를 초과하지 않도록 하기 위한 대책을 제시하고자 하였다. 우선 먼저 survey meter를 이용하여 본원 핵의학과 17개 구역의 방사능 측정값과 배후방사능 측정값을 비교한 결과 법적인 허용치를 초과하지는 않았지만, 이 중 11개 구역에서 의료 폐기함과 배후방사능이 통계적으로 유의한 차이를 보여 실제 방사능이 존재함을 알 수 있었다. 이에 좀 더 정확한 방사능을 측정하고자 감마카운터를 이용하여 각각의 의료폐기함으로부터 알코올솜, poly glove, 방사의약실에서 배출되는 생리식염수에서 각각 30개씩 표본 추출하여 측정한 결과, 높은 수준의 방사능이 측정되었으며, 일부는 법적 허용치를 초과했다. 따라서 의료폐기함으로 폐기되는 알코올솜과 poly glove는 각 영상실과 방사의약실에 구비된 방사성폐기함에 폐기하고, 방사의약실에서 발생되는 생리식염수는 액체폐기물로써 RI정화조에 폐기하거나 또는 방사성 자체 폐기절차에 따라 일정기간 보관하여 충분히 감쇄시킨 후 폐기해야 할 것이라 사료된다.

  • PDF

F-18-FDG PET을 이용한 유방종괴의 감별진단과 유방암의 병기설정 (Differential Diagnosis of Breast Mass and Staging of Breast Cancer Using F-18-FDG PET)

  • 여정석;이동수;강건욱;노동영;정준기;이명철
    • 대한핵의학회지
    • /
    • 제33권6호
    • /
    • pp.502-511
    • /
    • 1999
  • 목적: 유방종괴를 감별진단하고 액와림프절전이를 진단하는 데 대한 F-18 FDG PET의 진단정확도를 알아보고자 하였다. 대상 및 방법: 수술 전 F-18 FDG PET을 시행한 42명의 환자에 대하여 PET의 진단성능을 수술 후 조직 소견과 비교하였다. 결과: F-18 FDG PET에 이상이 있고 수술한 20명의 환자중 19명에서 암이 확인되었다. 반면 F-18 FDG PET에 이상 소견이 없는 상태에서 수술한 2명의 환자는 모두 양성종양이었다. F-18 FDG PET에 이상 소견이 없고 추적관찰만 한 환자 16명에서는 모두 암의 증거가 없었다. 수술로 확인된 F-18 FDG PET의 유방종괴 감별진단력은 예민도 95% (19/20) 특이도 17% (7/9), 양성예측도 86% (19/22), 음성예측도 87% (7/8)였다. 위양성은 염증 소견이 동반되었던 경우였고 위음성은 종양조직이 매우 적었던 경우였다. 과거에 유방성형술을 받았던 환자군 17명에서 F-18 FDG PET의 음성예측도는 93% (13/14)였다. 액와탐색수술을 시행한 17명의 환자에서 F-18 FDG PET의 예민도는 73% (8/11), 특이도는 100% (7/7), 양성예측도는 100% (8/8), 음성예측도는 70% (7/0)였다. 수술시 유방종괴가 양성종양으로 확인되어 더 이상 그쪽 액와탐색수술하지 않았던 예를 F-18-FDG PET이 모두 음성결과를 보였던 것까지 포함하면 음성예측도는 87% (20/23)였다. 결론: 유방암 환자에서 F-18-FDG PET의 진단성능이 우수하였고 액와림프절전이의 진단에 도움이 된다.

  • PDF

장비정도관리에 Calibrator[I-125] Set 적용 (The Application of New Calibrator[I-125]Set for Equipment Quality Management)

  • 김지나;안재석;원우재
    • 핵의학기술
    • /
    • 제19권2호
    • /
    • pp.108-111
    • /
    • 2015
  • Purpose Lately, in accordance with the increasing interest about Healthcare accreditation program and International laboratory accreditation scheme, requirements about the instrument quality management are gradually taking shape. In nuclear medicine In vitro laboratory, the most typical instruments are multi detector gamma counter and automatic dispensing system. Each laboratory continue with the quality control adequate for circumstances. The purpose of this study is to application and establish the new Calibrator[I-125]Set which is efficient at standardization of equipment quality management. Materials and Methods Deviation between detectors were measured with 12 solid samples of the Calibrator[I-125]Set. their activities differ from each other by less than 1%. Multi detector gamma counters are GAMMA-10;Shinjin medics. Inc, Goyansi, Korea(Gamma counter A), SR300;Stratec biomedical systems AG, Gewerbestr, Germany(Gamma counter B) and COBRA II; Packard Instrument Co. Inc, Meriden, USA(Gamma counter C). Evaluation of two automatic dispensing system used A, B liquid tracer of the Calibrator[I-125]Set. After dispensing and counting, calculated using the ratio of the measured value and proposed value. We used solution A for 20, 25ul and solution B for 50, 100ul. Method of data analysis and reference range was provided by kit documentation. Furthermore, we could calculate our counter efficiency indirectly. Results The CV(%) of measured values by Gamma counter A, B, C are 0.34, 0.70, 1.30. Calculated value are 1.05314, 2.10419, 4.08485. Provided reference range is less than 3. A dispensing system's calculated values are 0.986, 0.989, 1.023, 1.017 and B are 0.874, 0.725, 1.021, 0.904. Provided reference range is from 0.95 to 1.05. Also, counter's efficiency are 74.18, 72.79, 74.32% at counter A, B, C and efficiency of the one detector counter is 79.26%. Conclusion If using this Calibrator[I-125]Set after verifying whether quality assurance, is applicable to equipment quality management on behalf of the role of gold standard.

  • PDF

타액선 신티그라피 검사에서 타액선 영상과 타액 제거율의 비교 연구 (The Comparison with Salivary Image and Saliva Clearance Rate in Salivary Scintigraphy)

  • 김영빈;신규설;박연경;김건재
    • 핵의학기술
    • /
    • 제13권1호
    • /
    • pp.15-19
    • /
    • 2009
  • Purpose: The aim of study is to find a correlation between Salivary clearance rate using saliva and blood and Secretion rate and Excretion rate using Salivary gland Scan images. Materials and Methods: Salivary Scan and Stimulate clearance of $^{99m}Tc$-pertechnate was performed in 20 patients with moderate function(group 1), 9 patients with severe function glands (group 2), 3 patients with non function (group 3) and normal 6 controls. Salivay clearance rate was compare with Secretion rate and Excretion rate of Salivary glands' ROI. Result: Stimulate salivary clearance of normal controls was 18.4 ml/min, salivary clearance of group 1 was 10.1 ml/min, salivary clearance of group 2 was 10.4 ml/min and salivary clearance of group 3 was 2.3 ml/min. Significant difference was found between normal controls and group 2,3 (p<0.05, p<0.05). Secretion rate and Excretion rate of normal controls was 21.6%, 24.6%, Secretion rate and Excretion rate of group 1 was 17.6%, 24.0%, Secretion rate and Excretion rate of group 2 was 8.8%, 13.9% and Secretion rate and Excretion rate of group 3 was 5.6%, 2.9%. Significant difference was found between normal controls and group 2,3 (p<0.05, p<0.05). Conclusions: Stimulate salivary clearance using saliva and blood and Secretion rate and Excretion rate using Salivary gland Scan images accord well together.

  • PDF

Barium 조영제의 농도 차이가 PET 검사에 미치는 영향 (Influence on PET Exam Caused by Density Differences of Barium-sulfate Contrast Media)

  • 최우준;신상기;남기표;박순기
    • 핵의학기술
    • /
    • 제12권1호
    • /
    • pp.27-32
    • /
    • 2008
  • Purpose: The evaluation of SUV (Standardized Uptake Values) for quantitative analysis in PET exam is the most significant. In PET exam, we make attenuation correction images by using $^{68}Ge$, $^{137}Cs$ or CT data. At this time, a distorted attenuation map affects quantitative analysis. After the exam using barium-sulfate and high density of barium contrast make attenuation map distorted. And then it brings bed influences on SUV. The aim of this study is to verify the relationship between high density barium-sulfate and SUV in PET exam. Materials and Methods By using $^{18}F$-FDG, we made barium-sulfate powder, density of 0, 1.5, 3, 5, 10 and 15% respectively and acquired PET and PET/CT images per each density. And we examined SUV variations from PET and PET/CT images according to differences of barium's density. Moreover, we finally calculated SUV causing variations in HU (Hounsfield Units) values to justify whether the differences of barium density bring any changes in PET/CT exam. Results: From PET images acquired from transmission scan with $^{68}Ge$, we got SUV figures from 6.46 to 6.8 in barium density between 0 to 15 percent. On the other hand, In PET images acquired from Tx scan that using CT, SUV was 6.77 to 23.73, derived from the same barium density. And CT HU values range from 29 to 2004. Conclusion: PET images from Tx data using $^{68}Ge$ weren't affected by barium density and had no differences in SUV. But in the PET/CT images using CT Tx data, there's considerable variations in HU and SUV values according to a difference of barium density in HU values. To perform a precise examination, barium sulfate should be removed from a human body before performing a PET exam.

  • PDF

ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway

  • Sun, Tong;Du, Bulin;Diao, Yao;Li, Xuena;Chen, Song;Li, Yaming
    • BMB Reports
    • /
    • 제52권7호
    • /
    • pp.457-462
    • /
    • 2019
  • [18F]Fluorodeoxyglucose (FDG) PET/CT imaging has been widely used in the diagnosis of malignant tumors. ATPase family AAA domain-containing protein 2 (ATAD2) plays important roles in tumor growth, invasion and metastasis. However, the relationship between [18F]FDG accumulation and ATAD2 expression remains largely unknown. This study aimed to investigate the correlation between ATAD2 expression and [18F]FDG uptake in lung adenocarcinoma (LUAD), and elucidate its underlying molecular mechanisms. The results showed that ATAD2 expression was positively correlated with maximum standardized uptake value ($SUV_{max}$), total lesion glycolysis (TLG), glucose transporter type 1 (GLUT1) expression and hexokinase2 (HK2) expression in LUAD tissues. In addition, ATAD2 knockdown significantly inhibited the proliferation, tumorigenicity, migration, [18F]FDG uptake and lactate production of LUAD cells, while, ATAD2 overexpression exhibited the opposite effects. Furthermore, ATAD2 modulated the glycometabolism of LUAD via AKT-GLUT1/HK2 pathway, as assessed using LY294002 (an inhibitor of PI3K/AKT pathway). In summary, to explore the correlation between ATAD2 expression and glycometabolism is expected to bring good news for anti-energy metabolism therapy of cancers.